› Forums › General Melanoma Community › MELANOMA “PREVENTIVE DRUGS”
- This topic has 12 replies, 3 voices, and was last updated 13 years, 5 months ago by
Amanda.
- Post
-
- August 22, 2012 at 6:50 pm
Have you all heard anything about this ??? I Just wrote about it in my HOME FROM MDA post, but wanted to bring special attention to it, as Dr. B. toldus again that it will be available by Oct. – Nov. of this year ! It's for people who are completely NED ! Supposedly, it prevents it rather than havingto take chemo/Zel – other kinds of treatment, forever !
Have you all heard anything about this ??? I Just wrote about it in my HOME FROM MDA post, but wanted to bring special attention to it, as Dr. B. toldus again that it will be available by Oct. – Nov. of this year ! It's for people who are completely NED ! Supposedly, it prevents it rather than havingto take chemo/Zel – other kinds of treatment, forever !
He will be back at a meeting in late Sept. 2012 for an update of the release date. We cannot find anything about it on the net. Would that be fantastic or WHAT !!! 🙂
YA'LL HEARD ANYTHING ABOUT IT FROM YOUR DOC ?
Nancy (devoted wife of 3 X Warrior Wayne)
- Replies
-
-
- August 22, 2012 at 8:10 pm
This may be what he is talking about.
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00841204
Official Title: “Phase II Trial of Sulindac in Individuals at Increased Risk for Melanoma”
This clinical trail info was updated in June this year, so it should be relevant.
Cheers.
Charlie S
-
- August 22, 2012 at 8:10 pm
This may be what he is talking about.
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00841204
Official Title: “Phase II Trial of Sulindac in Individuals at Increased Risk for Melanoma”
This clinical trail info was updated in June this year, so it should be relevant.
Cheers.
Charlie S
-
- August 22, 2012 at 8:10 pm
This may be what he is talking about.
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00841204
Official Title: “Phase II Trial of Sulindac in Individuals at Increased Risk for Melanoma”
This clinical trail info was updated in June this year, so it should be relevant.
Cheers.
Charlie S
-
- August 22, 2012 at 10:22 pm
Congrats on your good report! Do you have the name of the drug, maker, or more info on whether it is supposed to be in a clinical trial setting? That would be so very helpful to know. I know GSK has applied for approval of both their BRAF and MEK inhibitor drugs. I’ve also heard that the BMS anti-PD1 could be approved for lung cancer first before mel, so might be available to us off-label, but haven’t heard any time table for it. You might try posting on melanoma international foundation board also. -
- August 22, 2012 at 10:22 pm
Congrats on your good report! Do you have the name of the drug, maker, or more info on whether it is supposed to be in a clinical trial setting? That would be so very helpful to know. I know GSK has applied for approval of both their BRAF and MEK inhibitor drugs. I’ve also heard that the BMS anti-PD1 could be approved for lung cancer first before mel, so might be available to us off-label, but haven’t heard any time table for it. You might try posting on melanoma international foundation board also. -
- August 22, 2012 at 10:22 pm
Congrats on your good report! Do you have the name of the drug, maker, or more info on whether it is supposed to be in a clinical trial setting? That would be so very helpful to know. I know GSK has applied for approval of both their BRAF and MEK inhibitor drugs. I’ve also heard that the BMS anti-PD1 could be approved for lung cancer first before mel, so might be available to us off-label, but haven’t heard any time table for it. You might try posting on melanoma international foundation board also.
-
- You must be logged in to reply to this topic.